Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bladder Cancer
  Free Subscription

Articles published in
Urology
    September 2025
  1. WESTERMAN ME, Delacroix SE Jr
    Editorial Comment: Muscle-Invasive Bladder Cancer Treatment Selection in an Emerging Treatment Era: A Patient Preference Study.
    Urology. 2025 Sep 4:S0090-4295(25)00838-6. doi: 10.1016/j.urology.2025.
    >> Share

    August 2025
  2. SMITH AB, Gore JL, Chisolm S, Squires P, et al
    Muscle-Invasive Bladder Cancer Treatment Selection in an Emerging Treatment Era: A Patient Preference Study.
    Urology. 2025 Aug 12:S0090-4295(25)00767-8. doi: 10.1016/j.urology.2025.
    >> Share

    July 2025
  3. OBIORA D, Yu M, Sharbaugh D, Bandari J, et al
    Treatment Patterns for Non-Muscle Invasive Bladder Cancer during the Bacillus Calmette-Guerin shortage.
    Urology. 2025 Jul 23:S0090-4295(25)00711-3. doi: 10.1016/j.urology.2025.
    >> Share

    June 2025
  4. MACINTYRE I, Kool R, Marcq G, Kulkarni GS, et al
    Effect of Sex Differences on Cancer Outcomes after Chemo-Radiation for Muscle-Invasive Bladder Cancer: A Retrospective Multicenter Cohort Study.
    Urology. 2025 Jun 28:S0090-4295(25)00636-3. doi: 10.1016/j.urology.2025.
    >> Share

  5. THAKUR A, Kumar L
    Reply to editor comment on "A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncologica
    Urology. 2025 Jun 16:S0090-4295(25)00600-4. doi: 10.1016/j.urology.2025.
    >> Share

  6. STARR S, Kazemi S, Moman P, Lin L, et al
    Disparities in Access to High Volume Centers for Muscle Invasive Bladder Cancer and its Association With Treatment Patterns and Outcomes.
    Urology. 2025 Jun 12:S0090-4295(25)00595-3. doi: 10.1016/j.urology.2025.
    >> Share

  7. BELAND LE, Van Batavia JP, Mittal S, Kolon TF, et al
    Inflammatory Myofibroblastic Tumor of the Bladder in Childhood: A Three Case Series.
    Urology. 2025;200:e72-e75.
    >> Share

    May 2025
  8. WANG J, Ma R, Wu X, Yang W, et al
    Letter to the Editor on "A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological O
    Urology. 2025 May 29:S0090-4295(25)00513-8. doi: 10.1016/j.urology.2025.
    >> Share

  9. HIGGINS MI, Li J, Ahmed W, Lu C, et al
    Detection Of High-Grade Bladder Cancer In Urine Samples Using In Situ Hybridization Of Long Non-Coding RNA UCA1.
    Urology. 2025 May 13:S0090-4295(25)00468-6. doi: 10.1016/j.urology.2025.
    >> Share

    April 2025
  10. ACOSTA AM, Saad M, Chaux A, Gordetsky JB, et al
    Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy: An International Multi-Institutional Study Comparing Isolated Nodal Disease versus Persistent Muscle-Invasive Disease.
    Urology. 2025 Apr 16:S0090-4295(25)00345-0. doi: 10.1016/j.urology.2025.
    >> Share

  11. LONGONI M, Penaranda NR, Marmiroli A, Falkenbach F, et al
    Reply to Editorial Comment on "Survival Outcomes And Temporal Trends Of Non-Surgical Management Versus Radical Cystectomy In Non-Organ-Confined Urothelial Bladder Cancer".
    Urology. 2025 Apr 15:S0090-4295(25)00341-3. doi: 10.1016/j.urology.2025.
    >> Share

  12. JOYCE DD
    Editorial Comment on "Real-World Economic Burden and Healthcare Resource Utilization of Radical Cystectomy and Trimodal Therapy for Bladder Cancer in the United States".
    Urology. 2025 Apr 7:S0090-4295(25)00317-6. doi: 10.1016/j.urology.2025.
    >> Share

  13. SAITO K, Nakayama A
    Editorial comments on Survival outcomes and temporal trends of non-surgical management versus radical cystectomy in non-organ-confined urothelial bladder cancer.
    Urology. 2025 Apr 4:S0090-4295(25)00319-X. doi: 10.1016/j.urology.2025.
    >> Share

    March 2025
  14. WILLIAMS SB, Yapici HO, Singhal PK, Weimer I, et al
    Real-World Economic Burden and Healthcare Resource Utilization of Radical Cystectomy and Trimodal Therapy for Bladder Cancer in the United States.
    Urology. 2025 Mar 21:S0090-4295(25)00280-8. doi: 10.1016/j.urology.2025.
    >> Share

  15. MALSHY K, Bandari J, Cheng Z, Kadambi S, et al
    Tailoring Cystoscopy Surveillance: Addressing the Needs of Frail Bladder Cancer Patients.
    Urology. 2025 Mar 21:S0090-4295(25)00253-5. doi: 10.1016/j.urology.2025.
    >> Share

  16. SADE JP, Ferraris F, Raman J
    The (Re) evolution in the treatment of bladder cancer.
    Urology. 2025 Mar 21:S0090-4295(25)00287-0. doi: 10.1016/j.urology.2025.
    >> Share

  17. LONGONI M, Penaranda NR, Marmiroli A, Falkenbach F, et al
    Survival outcomes and temporal trends of non-surgical management versus radical cystectomy in non-organ-confined urothelial bladder cancer.
    Urology. 2025 Mar 6:S0090-4295(25)00216-X. doi: 10.1016/j.urology.2025.
    >> Share

  18. CETIN T, Bolat D, Akgul M, Yazici S, et al
    Effect of Bacillus Calmette-Guerin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor.
    Urology. 2025;197:126-132.
    >> Share

    February 2025
  19. TRIPATHY R, Kumar L
    Editorial Comment on "A comparison between intravesical Gemcitabine plus Docetaxel and intravesical BCG in the treatment of non-muscle invasive naive urinary bladder cancer: A systematic review and meta-analysis of oncological outcomes".
    Urology. 2025 Feb 19:S0090-4295(25)00176-1. doi: 10.1016/j.urology.2025.
    >> Share

  20. MICHAEL PD, Campbell RA
    Editorial comment on "A comparison between intravesical Gemcitabine plus Docetaxel and intravesical BCG in the treatment of non-muscle invasive naive urinary bladder cancer: A systematic review and meta-analysis of oncological outcomes".
    Urology. 2025 Feb 10:S0090-4295(25)00139-6. doi: 10.1016/j.urology.2025.
    >> Share

    January 2025
  21. KUMAR S, Razaqi N, Mehta R, Sah R, et al
    Comment on "Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis".
    Urology. 2025 Jan 29:S0090-4295(25)00008-1. doi: 10.1016/j.urology.2025.
    >> Share

  22. TRIPATHY R, Kumar L, Agarwal S, Thakur A, et al
    A comparison between intravesical gemcitabine plus docetaxel and intravesical BCG in the treatment of non-muscle invasive naive urinary bladder cancer: A systematic review and meta-analysis of oncological outcomes.
    Urology. 2025 Jan 9:S0090-4295(25)00006-8. doi: 10.1016/j.urology.2025.
    >> Share

    December 2024
  23. ECKE TH, Meisl CJ, Schlomm T, Rabien A, et al
    Performance of urinary markers in patients with suspicious cystoscopy during follow-up of recurrent non-muscle invasive bladder cancer: BTA stat(R), NMP22(R) BladderChek(R), UBC(R) Rapid Test, CancerCheck(R) UBC(R) rapid VISUAL, and uromonitor(R) in c
    Urology. 2024 Dec 1:S0090-4295(24)01113-0. doi: 10.1016/j.urology.2024.
    >> Share

  24. ZENG E, Saucke M, Pati B, Rose A, et al
    "...I Wish Someone Told Me About That...": A Qualitative Assessment of the Educational Needs of Patients Undergoing Cystectomy.
    Urology. 2024;194:348-355.
    >> Share

  25. MEKAYTEN M, Tin AL, Sidhu A, Liso N, et al
    Trans Oblique Ileal Conduit Technique Has a Low Risk of Parastomal Hernias.
    Urology. 2024;194:241-246.
    >> Share

    November 2024
  26. YEGUEZ AC, Talwar R, Smith AL
    Optimizing Care for Women through Gynecologic Organ Considerations During Cystectomy: A Pre-Operative Checklist of Important Considerations.
    Urology. 2024 Nov 28:S0090-4295(24)01095-1. doi: 10.1016/j.urology.2024.
    >> Share

  27. LIU H, Jin L, Shi J
    Incidence and risk factors for postoperative acute kidney injury after radical cystectomy for bladder cancer.
    Urology. 2024 Nov 25:S0090-4295(24)01092-6. doi: 10.1016/j.urology.2024.
    >> Share

  28. SANKIN A, Dave P, Cherrill LR, Boucher RH, et al
    Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over Time.
    Urology. 2024;193:166-172.
    >> Share

  29. SANCHEZ B C, Rickard M, Denburg A, Khondker A, et al
    Bladder Embryonal Rhabdomyosarcoma Presenting in the Perinatal Period: Report of Two Consecutive Cases.
    Urology. 2024;193:e85-e88.
    >> Share

  30. ABOU HEIDAR N, Mahmood AW, Khan M, Harrington G, et al
    Does Ta Low-grade Urothelial Carcinoma of the Bladder With Focal High-grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center Experience.
    Urology. 2024;193:136-142.
    >> Share

    October 2024
  31. OZDEMIR MS, Keskin ET, Savun M, Yuzkan S, et al
    VI-RADS-Based Algorithm for Bladder Cancer Management Randomized Retrospective Study.
    Urology. 2024 Oct 17:S0090-4295(24)00867-7. doi: 10.1016/j.urology.2024.
    >> Share

  32. AIZPURUA XP, Gardiner JIM, Popescu OB, Gonzalez EB, et al
    A Systematic Review on the Current Landscape of T1 Bladder Cancer Substaging.
    Urology. 2024 Oct 8:S0090-4295(24)00880-X. doi: 10.1016/j.urology.2024.
    >> Share

    September 2024
  33. FU H, Anele UA, Messer JC
    Editorial Commentary on: "Exposures and Bladder Cancer Risk Among Military Veterans: A Systematic Review and Meta-analysis".
    Urology. 2024 Sep 10:S0090-4295(24)00793-3. doi: 10.1016/j.urology.2024.
    >> Share

  34. KRONSTEDT S, Saffati G, Hinojosa-Gonzalez DE, Doppalapudi SK, et al
    Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Urology. 2024 Sep 2:S0090-4295(24)00770-2. doi: 10.1016/j.urology.2024.
    >> Share

  35. DALL CP, Liu X, Faraj KS, Srivastava A, et al
    Teaching Hospitals and Textbook Outcomes After Major Urologic Cancer Surgery.
    Urology. 2024;191:64-70.
    >> Share

    August 2024
  36. KRONSTEDT S, Cathey J, Chiu CB, Saffati G, et al
    Exposures and Bladder Cancer Risk Among Military Veterans: A Systematic Review and Meta-analysis.
    Urology. 2024 Aug 15:S0090-4295(24)00659-9. doi: 10.1016/j.urology.2024.
    >> Share

  37. TABER C, Lee B, Djang R, Shone E, et al
    Evaluating the Differences of Wound Related Complications in Robotically Assisted Radical Cystectomy vs Open Radical Cystectomy.
    Urology. 2024;190:56-62.
    >> Share

  38. RICH JM, Sfakianos JP
    Reply to Editorial Comment on "Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis".
    Urology. 2024;190:54-55.
    >> Share

  39. COWAN AN, Rosen GH
    Editorial Comment on "Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis".
    Urology. 2024;190:53.
    >> Share

  40. RICH JM, Geduldig J, Elkun Y, Lavallee E, et al
    Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis.
    Urology. 2024;190:46-52.
    >> Share

    July 2024
  41. RICHARDS KA
    Editorial comment on "Sequential intravesical chemotherapy for treatment naive, high-risk non-muscle invasive bladder cancer: oncologic outcomes, tolerance, and comparison to contemporary controls.
    Urology. 2024 Jul 21:S0090-4295(24)00591-0. doi: 10.1016/j.urology.2024.
    >> Share

    June 2024
  42. CABRAL JD, Modi PK
    Editorial Comment on "Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer".
    Urology. 2024 Jun 20:S0090-4295(24)00469-2. doi: 10.1016/j.urology.2024.
    >> Share

  43. LIU WJ, Campbell RA, Michael PD, Wood A, et al
    Clinical upstaging after neoadjuvant chemotherapy impacting eligibility for vaginal-sparing cystectomy: identifying bladder cancer patients who may benefit from interim imaging.
    Urology. 2024 Jun 20:S0090-4295(24)00474-6. doi: 10.1016/j.urology.2024.
    >> Share

  44. REFUGIA JM, Roebuck E, Thakker P, Sandberg M, et al
    Sequential Intravesical Chemotherapy for Treatment Naive, High-Risk Non-Muscle Invasive Bladder Cancer: Oncologic Outcomes, Tolerance, and Comparison to Contemporary Controls.
    Urology. 2024 Jun 19:S0090-4295(24)00463-1. doi: 10.1016/j.urology.2024.
    >> Share

  45. CONNORS C, Wang D, Levy M, Ravivarapu KT, et al
    Transurethral Resection of Bladder Tumor Outcomes Are Predicted by a 5-Item Frailty Index.
    Urology. 2024;188:104-110.
    >> Share

    May 2024
  46. SEKAR RR, Irani S, Maganty A, Montgomery JS, et al
    Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Urology. 2024 May 17:S0090-4295(24)00359-5. doi: 10.1016/j.urology.2024.
    >> Share

  47. YU J, Wang CG, Zhang Y, Yang W, et al
    A Novel Approach to Treatment with Antiangiogenic Agents in Adenocarcinoma of Urachal Origin.
    Urology. 2024;187:121-122.
    >> Share

  48. BRANDT SB, Kingo PS, Laurberg JR, Lam GW, et al
    Reply to Editorial comments on "Definition of Benign Ureteroenteric Anastomotic Strictures in Ileal Conduits After Radical Cystectomy: Experience From a Single Center and Previously Published Literature".
    Urology. 2024;187:139.
    >> Share

  49. BRANDT SB, Kingo PS, Laurberg JR, Lam GW, et al
    Definition of Benign Ureteroenteric Anastomotic Strictures in Ileal Conduits After Radical Cystectomy: Experience From a Single Center and Previously Published Literature.
    Urology. 2024;187:131-136.
    >> Share

  50. LIN JS, Zhao LC
    Editorial comments on "Definition of Benign Ureteroenteric Anastomotic Strictures in Ileal Conduits After Radical Cystectomy: Experience From a Single Center and Previously Published Literature".
    Urology. 2024;187:137-138.
    >> Share

  51. MORAN M, Kim JE, Fu MZ, Ghodoussipour S, et al
    Worsening Neobladder Incontinence in a Patient on Nivolumab Therapy.
    Urology. 2024;187:92-93.
    >> Share

    April 2024
  52. EULE CJ, Warren A, Kuna EM, Callihan EB, et al
    Neoadjuvant cisplatin-based chemotherapy in nonmetastatic muscle-invasive bladder cancer: A systematic review and pooled meta-analysis to determine the preferred regimen.
    Urology. 2024 Apr 27:S0090-4295(24)00306-6. doi: 10.1016/j.urology.2024.
    >> Share

  53. HARDESTY JK, Burns RT, Soyster ME, Jansen NE, et al
    Female Bladder Dysfunction Following Boari Bladder Flap Ureteral Reconstruction.
    Urology. 2024;186:31-35.
    >> Share

    March 2024
  54. HUELSTER HL, Mason NT, Davaro F, Naqvi SMH, et al
    Cost-Utility of Initial Management of High-grade T1 Bladder Cancer with Intravesical BCG vs Immediate Radical Cystectomy.
    Urology. 2024 Mar 9:S0090-4295(24)00126-2. doi: 10.1016/j.urology.2024.
    >> Share

  55. SAHNI DS, Oberoi AS, Ramsaha S, Teahan S, et al
    Incidence of Ureteroenteric Anastomotic Strictures After Robotic vs Open Cystectomy in Adults.
    Urology. 2024;185:100-108.
    >> Share

    February 2024
  56. LIBLIK K, Queen JC, Touma NJ
    Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences.
    Urology. 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.
    >> Share

  57. CARLTON CE, Christie AL, Prokesch BC, Chao TC, et al
    Robotic simple cystectomy as a last resort for antibiotic-recalcitrant recurrent urinary tract infections in women.
    Urology. 2024 Feb 21:S0090-4295(24)00108-0. doi: 10.1016/j.urology.2024.
    >> Share

  58. LEPOR H, Wiegand L, Patel K, Du W, et al
    A Randomized Clinical Trial Evaluating Indigo Carmine as a Visualization Aid for Evaluating Ureteral Patency.
    Urology. 2024;184:105-111.
    >> Share

  59. WEISS K, Abimbola O, Miller K, Kim WY, et al
    Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report.
    Urology. 2024;184:75-78.
    >> Share

    January 2024
  60. MORRIS KE, Pappas TN
    Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
    Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
    >> Share

  61. PETEINARIS A, Gkeka K, Katsakiori P, Tatanis V, et al
    Replicating Florence Intracorporeal Neobladder Technique in Laparoscopic Radical Cystectomy: A Retrospective Study.
    Urology. 2024;183:106-110.
    >> Share

  62. KIM AH, Ruel NH, Yamzon J, Zhumkhawala AA, et al
    Indiana Pouch Continent Cutaneous Urinary Diversion After Robotic-assisted Radical Cystectomy: A 16-Year Experience.
    Urology. 2024;183:e325-e327.
    >> Share

    December 2023
  63. RICHARDS HL, Fortune DG, Lyons L, Curtin Y, et al
    Patients' emotional talk during surveillance cystoscopy for non-muscle invasive bladder cancer - opportunities for improving communication.
    Urology. 2023 Dec 29:S0090-4295(23)01116-0. doi: 10.1016/j.urology.2023.
    >> Share

  64. ZHU A, Srivastava A
    Editorial Comment: Does Alexis Wound Protector/Retractor Reduce the Risk of Surgical Site Infections After Open Radical Cystectomy for Bladder Cancer? Results From a Single Center, Comparative Study.
    Urology. 2023 Dec 14:S0090-4295(23)00958-5. doi: 10.1016/j.urology.2023.
    >> Share

  65. GUL ZG, Wu S, Raver M, Vasan R, et al
    A Multipronged Intervention to Reduce Readmissions and Readmission Intensity After Radical Cystectomy.
    Urology. 2023;182:155-160.
    >> Share

    November 2023
  66. GALOSI AB, Fave RFD, Perpepaj L, Milanese G, et al
    Does Alexis(c) wound protector/retractor reduce the risk of surgical site infections after open radical cystectomy for bladder cancer? Results from a single center, comparative study.
    Urology. 2023 Nov 6:S0090-4295(23)00951-2. doi: 10.1016/j.urology.2023.
    >> Share

  67. ARCEO-OLAIZ R, Smith EA, Stokes C, Eaton BR, et al
    Use of Perirectal Hyaluronic Acid Spacer Prior to Radiotherapy in a Pediatric Patient With Bladder Rhabdomyosarcoma: A Case Report.
    Urology. 2023;181:136-140.
    >> Share

  68. TUA-CARACCIA R, Livingston A, Routh JC
    Recurrent Papillary Bladder Tumors in a Boy With Lynch Syndrome.
    Urology. 2023;181:133-135.
    >> Share

    October 2023
  69. HYLLESTED E, Vejlgaard M, Stroomberg HV, Maibom SL, et al
    Reply by Authors: Acute Kidney Injury Within 90Days of Radical Cystectomy for Bladder Cancer: Incidence and Risk Factors.
    Urology. 2023 Oct 21:S0090-4295(23)00810-5. doi: 10.1016/j.urology.2023.
    >> Share

  70. GRECO F, Domanico L, Lembo F
    Editorial Comment to Acute Kidney Injury Within 90Days of Radical Cystectomy for Bladder Cancer: Incidence and Risk Factors.
    Urology. 2023 Oct 21:S0090-4295(23)00809-9. doi: 10.1016/j.urology.2023.
    >> Share

    September 2023
  71. HYLLESTED E, Vejlgaard M, Stroomberg HV, Maibom SL, et al
    Acute Kidney Injury within 90 days of Radical Cystectomy for Bladder Cancer: Incidence and Risk Factors.
    Urology. 2023 Sep 22:S0090-4295(23)00807-5. doi: 10.1016/j.urology.2023.
    >> Share

  72. VEJLGAARD M, Maibom SL, Joensen UN, Moser C, et al
    Microbial trends in infection-related readmissions following radical cystectomy for bladder cancer.
    Urology. 2023 Sep 22:S0090-4295(23)00805-1. doi: 10.1016/j.urology.2023.
    >> Share

  73. PENN T, Borza T, Liou JI, Jason Abel E, et al
    The Impact of Agent Orange Exposure on Non-Muscle Invasive Bladder Cancer Outcomes.
    Urology. 2023 Sep 18:S0090-4295(23)00794-X. doi: 10.1016/j.urology.2023.
    >> Share

  74. NABAVIZADEH R, Pessoa RR, Dumbrava MG, Packiam VT, et al
    Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series.
    Urology. 2023 Sep 7:S0090-4295(23)00733-1. doi: 10.1016/j.urology.2023.
    >> Share

  75. LYALL V, Aziz Ould Ismail A, Haggstrom DA, Issa MM, et al
    Accurate Documentation Contributes to Guideline-concordant Surveillance of Non-Muscle Invasive Bladder Cancer: a Multi-site VA Study.
    Urology. 2023 Sep 1:S0090-4295(23)00729-X. doi: 10.1016/j.urology.2023.
    >> Share

  76. MAJDALANY SE, Yaguchi G, Arora S, Ray C, et al
    Genital Sparing Robot-Assisted Radical Cystectomy with Intracorporeal Neobladder & Paravaginal Repair.
    Urology. 2023;179:202-203.
    >> Share

    August 2023
  77. RANTI D, Dey L, Bieber C, Grauer R, et al
    Surveillance for Non-Muscle Invasive Bladder Cancer: Identifying the point of Diminishing Returns.
    Urology. 2023 Aug 19:S0090-4295(23)00697-0. doi: 10.1016/j.urology.2023.
    >> Share

  78. HYMAN MJ, Skolarus TA, Litwack K, Meltzer DO, et al
    Outcomes of Hematuria Evaluation by Advanced Practice Providers and Urologists.
    Urology. 2023;178:67-75.
    >> Share

    July 2023
  79. PASTER IC, Chipollini J
    Reply: Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients.
    Urology. 2023 Jul 11:S0090-4295(23)00448-X. doi: 10.1016/j.urology.2023.
    >> Share

  80. SEKAR RR, Maganty A
    Impact of Race, Ethnicity, and Gender on Response to Neoadjuvant Chemotherapy and Survival in Patients With Muscle-invasive Bladder Cancer.
    Urology. 2023 Jul 11:S0090-4295(23)00447-8. doi: 10.1016/j.urology.2023.
    >> Share

  81. JEVNIKAR B, Slopnick E, Almassi N
    Clinical Challenge in Urology: Late Genitourinary Toxicity Following Intravesical Bacillus Calmette-Guerin.
    Urology. 2023;177:e8-e9.
    >> Share

  82. GELDMAKER LE, Baird BA, Hasse CH, Haehn DA, et al
    Analysis of Transurethral Resection of Bladder Tumor Efficiency Utilizing Nonprocedural Operating Room Times.
    Urology. 2023;177:6-11.
    >> Share

  83. KANABOLO DL, Park S
    Prophylactic Mesh Placement With Ileal Conduit: A Cost-effectiveness Analysis.
    Urology. 2023;177:197-203.
    >> Share

  84. FENG S, Yang Y, Yu Z, Xiong Q, et al
    Survival and Analysis of Prognostic Factors for Bladder Malignancies in Children and Adolescents: A Population-based Study.
    Urology. 2023;177:156-161.
    >> Share

  85. SOYSTER ME, Arnold PJ, Burns RT, Zappia JL, et al
    Ileal Ureter Utilization in Patients With Previous Urinary Diversions.
    Urology. 2023;177:184-188.
    >> Share

    June 2023
  86. TAN WP
    An Atypical Bladder Mass: Extra Adrenal Paraganglioma.
    Urology. 2023;176:e8-e9.
    >> Share

  87. ERGUN O, Alperen Ozturk S, Kircicek F, Gurdal O, et al
    Increased Plasma Ignition Distance Practice may Prevent the Obturator Reflex Occurrences and Compare of its Effectiveness Versus Obturator Block: A Prospective, Randomized, Controlled Study.
    Urology. 2023;176:226-231.
    >> Share

    May 2023
  88. PASTER IC, Zeng J, Recio-Boiles A, Chipollini J, et al
    Gender, racial and ethnic differences in pathologic response following neoadjuvant chemotherapy for bladder cancer patients.
    Urology. 2023 May 23:S0090-4295(23)00446-6. doi: 10.1016/j.urology.2023.
    >> Share

  89. WAHLEN MM, McElree IM, Packiam VT
    Editorial Comment On: Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the BCG Drug Shortage.
    Urology. 2023 May 19:S0090-4295(23)00371-0. doi: 10.1016/j.urology.2023.
    >> Share

  90. GROOTEMAAT M, Tjiam I, Sampimon D, Bot F, et al
    Bilateral Adrenal and testicular Tumours; When a Simple Diagnosis Becomes Complicated.
    Urology. 2023;175:e11-e12.
    >> Share

    April 2023
  91. MILLER DT, Sun Z, Grajales V, Pekala KR, et al
    Insurance type and area deprivation are associated with worse overall mortality for patients with muscle-invasive bladder cancer.
    Urology. 2023 Apr 5:S0090-4295(23)00270-4. doi: 10.1016/j.urology.2023.
    >> Share

  92. ZHANG JH, Starr SL, Chamie K
    Contemporary Systemic Therapies in Urothelial Carcinoma.
    Urology. 2023;174:150-158.
    >> Share

  93. JUE JS, Armenakas NA
    Upper Tract Tumor En Bloc Enucleation: A Novel Approach to the Diagnosis and Management of Upper Tract Urothelial Carcinoma.
    Urology. 2023;174:196-200.
    >> Share

  94. SONG SH, Kim JH, Lee S, Hong SK, et al
    Total Intracorporeal Versus Open Bladder Cuffing in Robotic Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Urology. 2023;174:111-117.
    >> Share

    March 2023
  95. CHUN B, He M, Jones C, Vasan R, et al
    Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the BCG Drug Shortage.
    Urology. 2023 Mar 25:S0090-4295(23)00267-4. doi: 10.1016/j.urology.2023.
    >> Share

  96. DONAT SM, Sonoda Y, Al-Ahmadie H, Murali R, et al
    Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract.
    Urology. 2023;173:10-16.
    >> Share

  97. RAM P, Mandal S, Das MK, Nayak P, et al
    Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guerin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Res
    Urology. 2023;173:229.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016